The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus.
The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus.
复制标题
DOI:
10.1038/ijo.2013.53
复制
发表时间:
2014-01
期刊:
影响因子:
--
通讯作者:
Vaisse C
中科院分区:
文献类型:
--
作者:
Aslan IR;Ranadive SA;Valle I;Kollipara S;Noble JA;Vaisse C
The central melanocortin system is essential for the regulation of long-term energy homeostasis in humans. Rodent experiments suggest that this system also affects glucose metabolism, in particular by modulating peripheral insulin sensitivity independently of its effect on adiposity. Rare patients with complete genetic defects in the central melanocortin system can provide insight into the role of this system in glucose homeostasis in humans. We here describe the eighth individual with complete POMC deficiency and the first with coincidental concomitant Type I Diabetes, which provides a unique opportunity to determine the role of melanocortins in glucose homeostasis in human. Direct sequencing of the POMC gene in this severely obese patient with isolated ACTH deficiency identified a homozygous 5′ UTR mutation −11C>A which we find to abolish normal POMC protein synthesis, as assessed in vitro. The patient’s insulin requirements were as expected for his age and pubertal developmental. This unique patient suggests that in humans, the central melanocortin system does not seem to affect peripheral insulin sensitivity, independently of its effect on adiposity.